SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-22-006325
Filing Date
2022-02-14
Accepted
2022-02-14 20:31:38
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5/A SUBMISSION doc5a.html 5/A  
1 FORM 5/A SUBMISSION doc5a.xml 5/A 4279
  Complete submission text file 0000899243-22-006325.txt   5814
Mailing Address C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380
Business Address
Nguyen Diem (Reporting) CIK: 0001814338 (see all company filings)

Type: 5/A | Act: 34 | File No.: 001-40629 | Film No.: 22636581

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)